These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 12702583)
21. Organophosphorous pesticides in breast cancer progression. Cabello G; Juarranz A; Botella LM; Calaf GM J Submicrosc Cytol Pathol; 2003 Jan; 35(1):1-9. PubMed ID: 12762645 [TBL] [Abstract][Full Text] [Related]
22. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells. Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049 [TBL] [Abstract][Full Text] [Related]
23. PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect. Trifilieff A; Bench A; Hanley M; Bayley D; Campbell E; Whittaker P Br J Pharmacol; 2003 May; 139(1):163-71. PubMed ID: 12746235 [TBL] [Abstract][Full Text] [Related]
24. Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers. Yee LD; Williams N; Wen P; Young DC; Lester J; Johnson MV; Farrar WB; Walker MJ; Povoski SP; Suster S; Eng C Clin Cancer Res; 2007 Jan; 13(1):246-52. PubMed ID: 17200362 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of chemopreventive agents in different mechanistic classes using a rat tracheal epithelial cell culture transformation assay. Arnold JT; Wilkinson BP; Sharma S; Steele VE Cancer Res; 1995 Feb; 55(3):537-43. PubMed ID: 7834622 [TBL] [Abstract][Full Text] [Related]
26. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone. Enomoto N; Takei Y; Hirose M; Konno A; Shibuya T; Matsuyama S; Suzuki S; Kitamura KI; Sato N J Pharmacol Exp Ther; 2003 Sep; 306(3):846-54. PubMed ID: 12805475 [TBL] [Abstract][Full Text] [Related]
27. ET-18-O-CH3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells. Na HK; Inoue H; Surh YJ FEBS Lett; 2005 Nov; 579(27):6279-87. PubMed ID: 16253239 [TBL] [Abstract][Full Text] [Related]
28. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Park H; Im JY; Kim J; Choi WS; Kim HS Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380 [TBL] [Abstract][Full Text] [Related]
29. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. Tao L; Liu HR; Gao E; Teng ZP; Lopez BL; Christopher TA; Ma XL; Batinic-Haberle I; Willette RN; Ohlstein EH; Yue TL Circulation; 2003 Dec; 108(22):2805-11. PubMed ID: 14610009 [TBL] [Abstract][Full Text] [Related]
31. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs. Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066 [TBL] [Abstract][Full Text] [Related]
32. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150 [TBL] [Abstract][Full Text] [Related]
33. Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line. Pignatelli M; Cocca C; Santos A; Perez-Castillo A Oncogene; 2003 Aug; 22(35):5446-50. PubMed ID: 12934104 [TBL] [Abstract][Full Text] [Related]
34. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2. Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476 [TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines. Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621 [TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis. Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396 [TBL] [Abstract][Full Text] [Related]
37. Novel cell culture models for prevention of human breast cancer (Review). Katdare M; Osborne MP; Telang NT Int J Oncol; 2003 Mar; 22(3):509-15. PubMed ID: 12579302 [TBL] [Abstract][Full Text] [Related]
38. Telomerase protects cancer-prone human cells from chromosomal instability and spontaneous immortalization. Elmore LW; Turner KC; Gollahon LS; Landon MR; Jackson-Cook CK; Holt SE Cancer Biol Ther; 2002; 1(4):391-7. PubMed ID: 12432253 [TBL] [Abstract][Full Text] [Related]
39. Quantitative morphometry of respiratory tract epithelial cells as a tool for testing chemopreventive agent efficacy. Sharma S; Gao P; Steele VE Anticancer Res; 2010 Mar; 30(3):737-42. PubMed ID: 20392991 [TBL] [Abstract][Full Text] [Related]